Court Reviews Decision to Stop Using SBA 8(a) Contract
Client Alert | less than 1 min read | 09.02.10
In K-Lak Corp. v. U.S. (Aug. 3, 2010), the Court of Federal Claims determined that it has jurisdiction to consider the claims that the Air Force had improperly decided to remove a requirement for credit reports from the 8(a) Program and instead had procured the reports through a GSA schedule in order to obtain lower prices. The court explained that, for purposes of determining its bid protest jurisdiction, the definition of "procurement" is broad and encompasses the agency's initial process of determining its needs.
Contacts
Insights
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage.
Client Alert | 6 min read | 09.14.26
Mental Health Parity Bulletin Restates Best Practices for Evaluating Compliance
Client Alert | 6 min read | 09.11.26
It’s LIVE: The Cyber Resilience Act Reporting Is Mandatory as of Today - 11 September 2026
Client Alert | 10 min read | 09.11.26
Mining, Indigenous Consultation Rights, and Investment Treaty Protection
